Tae‐You Kim
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Hepatology top 0.5%
- Cancer Research top 1%
- Co-authors
- Seock‐Ah ImYung‐Jue BangSae‐Won HanDo‐Youn OhDae Seog HeoDong‐Wan KimKyung-Hun LeeSe‐Hoon Lee
- Topics
- Colorectal Cancer Treatments and Studies (47 papers)Lung Cancer Treatments and Mutations (32 papers)Hepatocellular Carcinoma Treatment and Prognosis (28 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Tae‐You Kim
186 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 4.3k
- Pulmonary and Respiratory Medicine 2.5k
- Molecular Biology 2.0k
- Hepatology 1.5k
- Cancer Research 1.5k
Countries citing papers authored by Tae‐You Kim
This map shows the geographic impact of Tae‐You Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae‐You Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae‐You Kim more than expected).
Fields of papers citing papers by Tae‐You Kim
This network shows the impact of papers produced by Tae‐You Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae‐You Kim. The network helps show where Tae‐You Kim may publish in the future.
Co-authorship network of co-authors of Tae‐You Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Tae‐You Kim. A scholar is included among the top collaborators of Tae‐You Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tae‐You Kim. Tae‐You Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 46 | |
| 3 | 187 | |
| 4 | 17 | |
| 5 | 20 | |
| 6 | Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer. | 8 |
| 7 | 109 | |
| 8 | 50 | |
| 9 | 18 | |
| 10 | 47 | |
| 11 | 62 | |
| 12 | 61 | |
| 13 | 106 | |
| 14 | 108 | |
| 15 | 196 | |
| 16 | The Differences of Behavioral and Psychological Symptoms in the Patients of Alzheimer's Disease and Vascular Dementia | 4 |
| 17 | The Differences of Clinical Features between Alzheimer's Disease and Vascular Dementia According to Progression | 0 |
| 18 | Histone deacetylase inhibitor down-regulates thymidylate synthase expression: Clinical implication of overcoming 5-fluoruracil resistance in human cancer cells | 1 |
| 19 | The Change of Behavioral and Psychological Symptoms according to the Progression of Alzheimer's Disease | 4 |
| 20 | The Relationship between the Degree of Activity of Daily Living and Clinical Features in Alzheimer's Disease | 4 |
About Tae‐You Kim
Tae‐You Kim is a scholar working on Oncology, Hepatology and Cancer Research, having authored 189 papers that have together received 7.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (47 papers), Lung Cancer Treatments and Mutations (32 papers) and Hepatocellular Carcinoma Treatment and Prognosis (28 papers). The work is most often cited by research in Hepatology (1.5k citations), Oncology (4.3k citations) and Cancer Research (1.5k citations). Tae‐You Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Seock‐Ah Im, Yung‐Jue Bang, Sae‐Won Han, Do‐Youn Oh, Dae Seog Heo, Dong‐Wan Kim, Kyung-Hun Lee, Se‐Hoon Lee, Jee Hyun Kim and Masatoshi Kudo. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.